Chrysalis Intelligence · Product Codes · NQD

NQD · Cardiac C-Reactive Protein, Antigen, Antiserum, And Control

Immunology · 3 clearances · 3 unique sponsors

Device class
Class II
Regulation 866.5270
Total clearances
3
2022-12-16 → 2026-04-02
Last 12 months
1
Unique sponsors
3
Definition

What is Cardiac C-Reactive Protein, Antigen, Antiserum, And Control

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.
Medical specialty
Immunology
Review panel
IM
Regulation number
866.5270
Implant
N
Life-sustain / support
N
GMP exempt
N
Third-party review
Y
Trend

Clearance volume by quarter

Players

Top sponsors in this product code

Sponsor Clearances Last 12 mo Most recent
Siemens Healthcare Diagnostics, Inc. 1 0 2024-01-18
Siemens Healthcare Diagnostics Products GmbH 1 0 2022-12-16
Roche Diagnostics 1 1 2026-04-02
Reimbursement

Likely billing codes (AI-inferred · verify with billing)

Healthcare providers using this device would typically bill under these HCPCS Level II (alphanumeric) or CPT (5-digit) codes. Mapping inferred from device function by Claude Haiku; official descriptions pulled from the CMS HCPCS April 2026 quarterly file where available. Always verify with billing/coding teams before relying on these.

CodeTypeDescriptionConfidenceRationale
86140 CPT High C-reactive protein measurement; cardiac risk stratification assay
Pulse

Most recent 510(k) clearances

DateK-numberSponsorDevice
2026-04-02 K260026 Roche Diagnostics Tina-quant Cardiac high sensitivity CRP III
2024-01-18 K233242 Siemens Healthcare Diagnostics, Inc. Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)
2022-12-16 K212559 Siemens Healthcare Diagnostics Products GmbH CardioPhase® hsCRP